Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation

MLA

Wei Han, et al. “Eltrombopag Is an Effective and Safe Therapy for Refractory Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation.” Bone Marrow Transplantation, vol. 54, Jan. 2019, pp. 1310–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3007418617e38ccad29a2182ca5d0441&authtype=sso&custid=ns315887.

APA

Wei Han, Yu-Qian Sun, Xiao-Dong Mo, Ting-Ting Han, Kai-Yan Liu, Feng-Rong Wang, Jing-Zhi Wang, Yu Wang, Lan-Ping Xu, Xiao-Jun Huang, Hai-Xia Fu, Chen-Hua Yan, Xiao-Hui Zhang, Huan Chen, & Yuan-Yuan Zhang. (2019). Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation. Bone Marrow Transplantation, 54, 1310–1318.

Chicago

Wei Han, Yu-Qian Sun, Xiao-Dong Mo, Ting-Ting Han, Kai-Yan Liu, Feng-Rong Wang, Jing-Zhi Wang, et al. 2019. “Eltrombopag Is an Effective and Safe Therapy for Refractory Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation.” Bone Marrow Transplantation 54 (January): 1310–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3007418617e38ccad29a2182ca5d0441&authtype=sso&custid=ns315887.